There was little mystery in seeing SonoSite (Nasdaq:SONO) get an acquisition bid. Not only has this relatively small manufacturer of portable ultrasound systems been a logical target for years, but the company began to actively and explicitly sell itself starting back in November. In a week that has seen another logical target (Synovis (Nasdaq:SYNO) get a bid from a not-so-likely buyer (Baxter (NYSE:BAX), the fact that it was Japan's Fujifilm that stepped up to buy the company makes this an a somewhat unusual story.

Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

The Deal
Fujifilm will be acquiring SonoSite for $995 million in cash, or about $54 per share. That's a 28% premium to Wednesday night's close and a 75% premium to the price of SonoSite's stock before it was widely known that the company was looking to sell. SonoSite is going out at a little more than three times trailing revenue, a multiple curiously similar to that of Synovis and one that is not all that robust by historical small-cap med-tech standards, but isn't so unreasonable given the performance of the company. (For related reading, see An Introduction To Small Cap Stocks.)

What Fujifilm is Getting
To SonoSite's credit, it managed to carve an almost 40% market share in the portable ultrasound market while competing with the giant General Electric (NYSE:GE) (which holds about 50% share). There's been ample litigation between the two companies for years, but SonoSite was able to make a name for itself with solid technology, good product features and a pure commitment to the portable market.

SonoSite basically succeeded by being willing to swim against the tide. While companies like GE, Siemens (NYSE:SI) and Phillips (NYSE:PHG) were hard at work developing more powerful "Big Iron" ultrasound systems for radiology departments, SonoSite saw the opportunity in point-of-care imaging. It would be inaccurate to say that SonoSite's hand-carried systems are just as good as the state-of-art installed systems, but that's not the point. Just as armies find use for both small arms and heavy artillery, so too are there appropriate times and places for both types of imaging systems.

Interestingly, although SonoSite has shown very impressive revenue growth over its many years, would-be rivals like Siemens, Phillips and Mindray (NYSE:MR) have never established any serious presence in this segment.

Wait A Minute ... Fujifilm?
Investors may be surprised to see Fujifilm stepping up to buy this company. After all, Fujifilm is still best known in the United States for its photographic film and its iconic green color schemes. While Fujifilm most definitely has its heritage in photographic film, the company has been very active in diversifying its business in recent years so as to avoid the fate of Polaroid and Eastman Kodak.

To that end, Fujifilm has targeted healthcare as an area of focus. In addition to legacy businesses in somewhat logical fields like X-ray systems and film, Fujifilm has looked for ways to leverage technological capabilities like control technology for chemicals and various production and analytical controls. Recently, in fact, Fujifilm formed a joint venture with Kyowa Hakko Kirin to produce biosimilar pharmaceuticals (basically generic versions of antibody therapies like Abbott's (NYSE:ABT) Humira).

The Bottom Line
Relative to the market today, SonoSite shareholders are getting a respectable deal. Yes, there is real potential in new products like the high-end Edge and the market for portable ultrasound is still under-penetrated. But it was not as though SonoSite was tearing up the market recently by its own efforts.

Given how long SonoSite was rumored to be on the block, it seems fair to assume that its bankers shopped this company to every logical buyer out there - including Siemens, Phillips, Samsung and perhaps even other Japanese companies like Hitachi or Olympus. Fujifilm's offer is likely the best that investors can, or should, expect. (For related reading, see Analyzing An Acquisition Announcement.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Stephen Simpson did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Stock Analysis

    The 5 Best Dividend Stocks in the Healthcare Sector

    Learn about the top five dividend stocks of companies operating in the health care sector that generate substantial cash flows to afford high payouts.
  2. Stock Analysis

    3 Stocks that Are Top Bets for Retirement

    These three stocks are resilient, fundamentally sound and also pay generous dividends.
  3. Investing News

    Are Stocks Cheap Now? Nope. And Here's Why

    Are stocks cheap right now? Be wary of those who are telling you what you want to hear. Here's why.
  4. Investing News

    4 Value Stocks Worth Your Immediate Attention

    Here are four stocks that offer good value and will likely outperform the majority of stocks throughout the broader market over the next several years.
  5. Investing News

    These 3 High-Quality Stocks Are Dividend Royalty

    Here are three resilient, dividend-paying companies that may mitigate some worry in an uncertain investing environment.
  6. Stock Analysis

    An Auto Stock Alternative to Ford and GM

    If you're not sure where Ford and General Motors are going, you might want to look at this auto investment option instead.
  7. Mutual Funds & ETFs

    The 4 Best Buy-and-Hold ETFs

    Explore detailed analyses of the top buy-and-hold exchange traded funds, and learn about their characteristics, statistics and suitability.
  8. Mutual Funds & ETFs

    What Exactly Are Arbitrage Mutual Funds?

    Learn about arbitrage funds and how this type of investment generates profits by taking advantage of price differentials between the cash and futures markets.
  9. Investing News

    Ferrari’s IPO: Ready to Roll or Poor Timing?

    Will Ferrari's shares move fast off the line only to sputter later?
  10. Stock Analysis

    5 Cheap Dividend Stocks for a Bear Market

    Here are five stocks that pay safe dividends and should be at least somewhat resilient to a bear market.
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  5. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!